|
WO2021061687A1
|
|
Compositions and methods for restoring or increasing tissue perfusion
|
|
US2021008115A1
|
|
Compositions and methods for restoring or increasing tissue perfusion
|
|
WO2021050629A1
|
|
Polymer drugs for cancer therapies
|
|
WO2021046099A1
|
|
PURE-PHASE CUBIC Ni1-xMox ALLOY NANOPARTICLES AS LOW-COST AND EARTH ABUNDANT ELECTROCATALYSTS
|
|
WO2021038526A1
|
|
Silicone coatings with improved properties
|
|
WO2021011592A1
|
|
Compounds as nlrp3 inflammasome inhibitors and compositions and uses thereof
|
|
WO2021007417A1
|
|
U-carbon: a novel metallic and magnetic carbon material statement regarding federally sponsored research or development
|
|
WO2020264070A1
|
|
Fabrication of aerogels and aerogel composites by ambient pressure sublimation of frozen solvents
|
|
WO2020227053A1
|
|
Vaginal microbiome markers for prediction and prevention of preterm birth and other adverse pregnancy outcomes
|
|
US2021016059A1
|
|
Guidewire systems and methods for preventing wire advancement into the body during catheterization
|
|
WO2020205459A1
|
|
Polymer agents for cardiopulmonary resuscitation
|
|
WO2020191327A1
|
|
Subwavelength antennas, drivers, and systems
|
|
WO2020186021A1
|
|
Method for forming flexible and biodegradable structures from low molecular weight chitin biopolymers
|
|
WO2020181158A1
|
|
Lipidic analogs of anti-cancer stem cell agent
|
|
WO2020214247A1
|
|
Low temperature formation of perovskite films in supercritical fluids
|
|
WO2020172348A1
|
|
Methods for diagnosis and/or therapy of disorders that correlate with dennd1a variant 2
|
|
WO2020163553A1
|
|
Mda-7/il-24 for cancer treatment and methods of monitoring same
|
|
WO2020163163A1
|
|
Augmented reality assisted training
|
|
WO2020146751A1
|
|
Device for secure, refrigerated storage of medicines
|
|
US2020384135A1
|
|
Cancer imaging with therapy: theranostics
|
